Related Experiment Videos
Using an information warehouse to screen patients for clinical trials: a prototype
Jyoti Kamal1, Kabardhi Pasuparthi, Patrick Rogers
1The Ohio State University Medical Center, Columbus, OH, USA.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|June 17, 2006
Summary
This study introduces a web-based prototype for efficient clinical trial patient screening. It helps researchers quickly identify eligible candidates using existing health data, improving drug discovery timelines.
Area of Science:
- Clinical Research Informatics
- Health Data Management
- Patient Recruitment Strategies
Background:
- Clinical trial success relies on timely patient identification and screening.
- Manual patient tracking is complex, time-consuming, and prone to errors.
- Efficient patient recruitment is crucial for drug discovery and developing new treatments.
Purpose of the Study:
- To develop a web-based prototype for automated clinical trial patient screening.
- To streamline the identification of eligible patients for clinical trials.
- To improve the efficiency and accuracy of the patient recruitment process.
Main Methods:
- Developed a web-based functional prototype at Ohio State University Medical Center (OSUMC).
- Utilized data from the Information Warehouse (IW) for patient screening.
- Implemented a system allowing researchers to apply inclusion/exclusion criteria to identify potential candidates.
Main Results:
- The prototype enables instant identification of potentially eligible patients for clinical trials.
- Researchers can screen patients based on specific protocol criteria without compromising patient identity.
- Provides access to comprehensive historical clinical data, including lab results, diagnoses, pathology reports, and clinical notes.
Conclusions:
- The developed prototype significantly enhances the efficiency of clinical trial patient screening.
- Automated screening using existing data can overcome manual tracking challenges.
- This tool facilitates faster patient identification, potentially accelerating drug discovery and treatment development.